Abiopharma

CG ONCOLOGY, INC. (CGON)

Symbol	CGON
Name	CG ONCOLOGY, INC.
Sector	UNDEFINED
Region	North America
Industry	Biological Products, (No Diagnostic Substances)
Address	400 SPECTRUM CENTER DRIVE,SUITE 2040, ¿IRVINE, California, 92618, United States
Telephone	(949) 409-3700
Fax	—
Email	—
Website	https://www.cgoncology.com
Incorporation	UNDEFINED
Incorporated On	—
Employees	—
Fiscal Year	—
Public Since	—
Exchanges	NASDAQ
Auditor	—
Audit Status	NOT PROVIDED
Reporting Status	—
CIK	0001991792
Description	CG Oncology is a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients afflicted with bladder cancer. We see a world where urologic cancer patients can benefit from our innovative immunotherapies to live with dignity and have an enhanced quality of life. Additional info from NASDAQ: CG Oncology is a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients afflicted with bladder cancer. We see a world where urologic cancer patients can benefit from our innovative immunotherapies to live with dignity and have an enhanced quality of life.

2026-07-29 20:29

📋 AMBAW BELLETE (Officer) plans to sell 4K shares of CG ONCOLOGY, INC. (at $73.50 each, total $316K) Filed: Jul 29, 2026 | ID: 007416

2026-07-28 20:58

📋 AMBAW BELLETE (Officer) plans to sell 50K shares of CG ONCOLOGY, INC. (at $72.50 each, total $3.6M) Filed: Jul 28, 2026 | ID: 007370

2026-07-27 22:45

CG Oncology Announces Publication of Pivotal Phase 3 BOND-003 Cohort C Study Results in The Lancet Oncology

2026-07-23 20:02

📋 AMBAW BELLETE (Officer) plans to sell 50K shares of CG ONCOLOGY, INC. (at $71.77 each, total $3.6M) Filed: Jul 23, 2026 | ID: 007270

2026-07-17 20:15

POST LEONARD E 🟡 adjusted position in 1.0K shares (1 derivative) of CG Oncology, Inc. (CGON) at $71.17 Transaction Date: Jul 15, 2026 | Filing ID: 307838

2026-07-15 20:24

📋 AMBAW BELLETE (Officer) plans to sell 52K shares of CG ONCOLOGY, INC. (at $72.77 each, total $3.8M) Filed: Jul 15, 2026 | ID: 007109

2026-06-29 21:26

Liu Brian Guan-Chyun 🟢 acquired 371.1K shares of CG Oncology, Inc. (CGON) at $66.87 ($24.8M) Transaction Date: Jun 25, 2026 | Filing ID: 026779

2026-06-24 20:37

📋 LEONARD POST (Director) plans to sell 5K shares of CG Oncology, Inc. (at $65.73 each, total $329K) Filed: Jun 24, 2026 | ID: 006467

2026-06-23 20:30

POST LEONARD E 🟡 adjusted position in 5.0K shares (1 derivative) of CG Oncology, Inc. (CGON) at $65.00 Transaction Date: Jun 22, 2026 | Filing ID: 279543

2026-06-22 20:49

📋 LEONARD POST (Director) plans to sell 6K shares of CG Oncology, Inc. (at $61.08 each, total $366K) Filed: Jun 22, 2026 | ID: 006393